T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$6.97B |
| 2 |
Advanced Micro Devices
AMD
|
+$1.37B |
| 3 |
lululemon athletica
LULU
|
+$1.32B |
| 4 |
Spotify
SPOT
|
+$1.28B |
| 5 |
ServiceNow
NOW
|
+$1.25B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$3.41B |
| 2 |
Northrop Grumman
NOC
|
+$2.36B |
| 3 |
Microsoft
MSFT
|
+$2.2B |
| 4 |
McDonald's
MCD
|
+$1.85B |
| 5 |
Intercontinental Exchange
ICE
|
+$1.28B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.34% |
| 2 | Healthcare | 16.78% |
| 3 | Financials | 13.77% |
| 4 | Consumer Discretionary | 12.98% |
| 5 | Communication Services | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Gray Television
GTN
$520M
| $34.7M | ﹤0.01% |
1,616,448
+9,860
| +0.6% | +$183K |
|
1027
NetEase
NTES
$78.5B
| $34.6M | ﹤0.01% |
563,825
-51,490
| -8% | -$3.02M |
|
|
EPZM
1028
DELISTED
Epizyme, Inc
EPZM
| $34.5M | ﹤0.01% |
1,403,093
+1,372,023
| +4,416% | +$20.4M |
|
1029
Garrett Motion
GTX
$5.47B
| $34.4M | ﹤0.01% |
3,445,422
-119,743
| -3% | -$1.22M |
|
1030
Utah Medical Products
UTMD
$230M
| $34.4M | ﹤0.01% |
318,683
-7,874
| -2% | -$798K |
|
1031
International Seaways
INSW
$4.71B
| $34.4M | ﹤0.01% |
1,154,373
-203,598
| -15% | -$5.3M |
|
1032
Quanterix
QTRX
$135M
| $34.1M | ﹤0.01% |
1,444,434
-185,247
| -11% | -$4.23M |
|
1033
RenaissanceRe
RNR
$13.2B
| $33.9M | ﹤0.01% |
172,783
-17,703
| -9% | -$3.35M |
|
1034
NOV
NOV
$7.45B
| $33.8M | ﹤0.01% |
1,348,945
+653,611
| +94% | +$14.7M |
|
1035
Agnico Eagle Mines
AEM
$93.8B
| $33.7M | ﹤0.01% |
546,228
+24,720
| +5% | +$1.44M |
|
1036
Steris
STE
$23B
| $33.3M | ﹤0.01% |
218,682
-114,886
| -34% | -$16.8M |
|
1037
CMS Energy
CMS
$22B
| $33.3M | ﹤0.01% |
530,270
+569
| +0.1% | +$35.5K |
|
1038
D.R. Horton
DHI
$40.8B
| $33M | ﹤0.01% |
626,396
-814
| -0.1% | -$43.5K |
|
1039
Jazz Pharmaceuticals
JAZZ
$16B
| $33M | ﹤0.01% |
221,314
+2,915
| +1% | +$397K |
|
1040
Hercules Capital
HTGC
$3.17B
| $33M | ﹤0.01% |
2,353,493
-31,421
| -1% | -$437K |
|
|
ECOL
1041
DELISTED
US Ecology, Inc.
ECOL
| $32.9M | ﹤0.01% |
568,749
-6,384
| -1% | -$379K |
|
1042
Lennar Class A
LEN
$20.5B
| $32.8M | ﹤0.01% |
608,070
-23,120
| -4% | -$1.32M |
|
1043
Amcor
AMCR
$21.4B
| $32.8M | ﹤0.01% |
604,855
+11,189
| +2% | +$561K |
|
1044
Citizens Financial Group
CFG
$31.1B
| $32.6M | ﹤0.01% |
802,315
-25,151
| -3% | -$941K |
|
|
GTT
1045
DELISTED
GTT Communications, Inc.
GTT
| $32.2M | ﹤0.01% |
2,833,545
+1,818,730
| +179% | +$15.2M |
|
1046
Phreesia
PHR
$780M
| $32.1M | ﹤0.01% |
1,205,614
+233,448
| +24% | +$6.45M |
|
|
RAPT
1047
DELISTED
RAPT Therapeutics
RAPT
| $31.9M | ﹤0.01% |
+147,904
| New | +$27.2M |
|
1048
James River Group Holdings
JRVR
$199M
| $31.9M | ﹤0.01% |
773,332
+36,118
| +5% | +$1.42M |
|
1049
Regions Financial
RF
$26.9B
| $31.7M | ﹤0.01% |
1,847,481
-71,970
| -4% | -$1.18M |
|
1050
Cloudflare
NET
$118B
| $31.7M | ﹤0.01% |
1,857,427
-142,573
| -7% | -$2.43M |
|
Similar funds
T. Rowe Price Associates's Q4 2019 Portfolio in Review
As of Q4 2019, T. Rowe Price Associates held 2,605 positions worth $771B, up 9.2% from $706B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
T. Rowe Price Associates's Q4 2019 filing shows 87 new, 1,561 increased, 802 reduced and 81 closed positions. Its largest new stake was XP: 7,905,172 shares worth $305M. The largest sale was Boeing, an estimated $3.41B.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2019 buy was XP: 7,905,172 shares worth $305M.
- T. Rowe Price Associates added most to Apple in Q4 2019, an estimated $6.97B increase.
- T. Rowe Price Associates's biggest Q4 2019 reduction was Boeing, cutting an estimated $3.41B.
- T. Rowe Price Associates fully exited Viacom Inc. Class B in Q4 2019, selling an estimated $204M.
- T. Rowe Price Associates's ten largest holdings make up 22% of its $771B portfolio in Q4 2019.
- T. Rowe Price Associates opened 87 new positions and closed 81 in Q4 2019.
- T. Rowe Price Associates's portfolio value rose 9.2% quarter-over-quarter to $771B.
Based on T. Rowe Price Associates's 13F filing for Q4 2019, filed 14 Feb 2020.